All In Biotech

Drug Trial Radar · NCT07018375

Effect of Oliceridine Patient-Controlled Intravenous Analgesia on Postoperative Chronic Pain After Video-Assisted Thoracoscopic Lung Resection

Effect of Oliceridine-based Intravenous Patient-Controlled Analgesia on Chronic Postsurgical Pain After Video-Assisted Thoracoscopic Lung Resection: A Multicenter Randomized Double-Blind Controlled Trial Protocol

Last checked: Nov 20, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 320 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

320

Planned (sponsor's estimate)

Start

Jan 6, 2026

Primary completion

Mar 31, 2027

Study completion Apr 30, 2027

Sponsor

Lead sponsor
Tianjin Medical University General HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
The No. 2 Hospital of Baoding; Tianjin Cancer Hospital Airport Hospital; Tianjin Medical University Second Hospital; North China University of Science and Technology; Haibin People's Hospital of Tianjin Binhai New Area; The People's Hospital of Jizhou District, Tianjin
First posted
Jun 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to evaluate the impact of oliceridine versus sufentanil for perioperative analgesia on the incidence of chronic postsurgical pain (CPSP) with functional impact in patients undergoing video-assisted thoracoscopic surgery.

Conditions

  • Chronic Postsurgical Pain

Interventions

  • OliceridineDrug

    postoperative patient-controlled analgesia (PCA)

  • SufentanilDrug

    Sufentanil

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of chronic postsurgical pain with functional impact at 3 months after surgeryTime frame: At 3 months after surgery (assessment window: postoperative day 90 +/- 14 days)

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Tianjin Medical University General Hospital

    Tianjin, China · Recruiting

  • Haibin People's Hospital of Tianjin Binhai New Area

    Tianjin, China · Recruiting

  • The People's Hospital of Jizhou District, Tianjin

    Tianjin, China · Recruiting

  • The Second Hospital of Tianjin Medical University

    Tianjin, China · Recruiting

  • Tianjin Cancer Hospital Airport Hospital

    Tianjin, China · Recruiting

  • The No. 2 Hospital of Baoding

    Baoding, Hebei, China · Recruiting

  • North China University of Science and Technology Affiliated Hospital

    Tangshan, Hebei, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.